Hannah Jones

Dr. Hannah Jones

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in mBio
Verified
Journal Article
Open access
PDF file
Sabrina GreenSabrina Green
Sabrina Green
CLCarmen Gu Liu
Carmen Gu Liu
XYXue Yu
Xue Yu
SGShelley Gibson
Shelley Gibson
Wilhelm SalmenWilhelm Salmen
Wilhelm Salmen
AMAnthony Maresso
Anthony Maresso
Invasive pathobionts or microbes capable of causing disease can reside deep within the mucosal epithelium of our gastrointestinal tract. Targeted effective antibacterial therapies are needed to combat these disease-causing organisms, many of which may be multidrug resistant.

28 September 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ARAnubama Rajan
Anubama Rajan
MRMatthew J. Robertson
Matthew J. Robertson
Hannah JonesHannah Jones
Hannah Jones
NPNina M. Poole
Nina M. Poole
JCJustin Clark
Justin Clark
AMAnthony Maresso
Anthony Maresso
Enteroaggregative Escherichia coli (EAEC) is a significant cause of acute and chronic diarrhea, foodborne outbreaks, infections of the immunocompromised, and growth stunting in children in developing nations. There is no vaccine and resistance to antibiotics is rising. Unlike related E. coli pathotypes that are often associated with acute bouts of infection, EAEC is associated with persistent diarrhea and subclinical long-term colonization. Several secreted virulence factors have been associated with EAEC pathogenesis and linked to disease in humans, less certain are the molecular drivers of adherence to the intestinal mucosa. We previously established human intestinal enteroids (HIEs) as a model system to study host-EAEC interactions and aggregative adherence fimbriae A (AafA) as a major driver of EAEC adherence to HIEs. Here, we report a large-scale assessment of the host response to EAEC adherence from all four segments of the intestine across at least three donor lines for five E. coli pathotypes. The data demonstrate that the host response in the duodenum is driven largely by the infecting pathotype, whereas the response in the colon diverges in a patient-specific manner. Major pathways altered in gene expression in each of the four enteroid segments differed dramatically, with responses observed for inflammation, apoptosis and an overwhelming response to different mucin genes. In particular, EAEC both associated with large mucus droplets and specific mucins at the epithelial surface, binding that was ameliorated when mucins were removed, a process dependent on AafA. Pan-screening for glycans for binding to purified AafA identified the human ligand as heparan sulfate proteoglycans (HSPGs). Removal of HSPG abrogated EAEC association with HIEs. These results may mean that the human intestine responds remarkably different to distinct pathobionts that is dependent on the both the individual and intestinal segment in question, and uncover a major role for surface heparan sulfate proteoglycans as tropism-driving factor in adherence and/or colonization. E. coli is a significant cause of worldwide diarrhea and systemic infection. We previously established human intestinal enteroids as a model system to study E. coli-host interactions. We report the first large-scale assessment of the host response to infection from all four segments of the intestine across different donor lines for five different pathotypes. Whereas the host response in the duodenum is driven by the infecting pathotype, the response in the colon diverges by donor. We observed a major upregulation of host mucins, particularly for EAEC, which led to the identification of heparan sulfate proteoglycans (HSPGs) as the receptor on human colonoids. Our research highlights a new role for HSPGs for EAEC infection.

28 June 2022 in mBio
Verified
Journal Article
Open access
FMFernando H. Martins
Fernando H. Martins
ARAnubama Rajan
Anubama Rajan
Hannah JonesHannah Jones
Hannah Jones
HBHamid R. Baniasadi
Hamid R. Baniasadi
AMAnthony W. Maresso
Anthony W. Maresso
VSVanessa Sperandio
Vanessa Sperandio
Enterohemorrhagic E. coli (EHEC) is a natural human pathogen that poorly colonizes mice. Hence, the use of murine models to understand features of EHEC infection is a challenge.

15 September 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AOAdilene Olvera
Adilene Olvera
Hannah JonesHannah Jones
Hannah Jones
ARAnubama Rajan
Anubama Rajan
LCLily G Carlin
Lily G Carlin
XYXiaomin Yu
Xiaomin Yu
POPablo C Okhuysen
Pablo C Okhuysen
The role of enteropathogenic Escherichia coli (EPEC) as a cause of diarrhea in cancer and immunocompromised patients is controversial. Quantitation of fecal bacterial loads has been proposed as a method to differentiate colonized from truly infected patients. We studied 77 adult cancer and immunosuppressed patients with diarrhea and EPEC identified in stools by FilmArray, 25 patients with pathogen-negative diarrhea, and 21 healthy adults without diarrhea. Stools were studied by quantitative polymerase chain reaction (qRT-PCR) for EPEC genes eaeA and lifA/efa-1 and strains characterized for virulence factors and adherence to human intestinal enteroids (HIEs). Patients with EPEC were more likely to have community-acquired diarrhea (odds ratio, 3.82 [95% confidence interval, 1.5–10.0]; P = .008) compared with pathogen-negative cases. Although EPEC was identified in 3 of 21 (14%) healthy subjects by qPCR, the bacterial burden was low compared to patients with diarrhea (≤55 vs median, 6 × 104 bacteria/mg stool; P < .001). Among EPEC patients, the bacterial burden was higher in those who were immunosuppressed (median, 6.7 × 103 vs 55 bacteria/mg; P < .001) and those with fecal lifA/ifa-1 (median, 5 × 104 vs 120 bacteria/mg; P = .015). Response to antimicrobial therapy was seen in 44 of 48 (92%) patients with EPEC as the sole pathogen. Antimicrobial resistance was common and strains exhibited distinct patterns of adherence with variable cytotoxicity when studied in HIEs. Cancer care was delayed in 13% of patients. Immunosuppressed cancer patients with EPEC-associated diarrhea carry high burden of EPEC with strains that are resistant to antibiotics, exhibit novel patterns of adherence when studied in HIEs, and interfere with cancer care.

17 July 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
GSGanesh Swaminathan
Ganesh Swaminathan
NKNabiollah Kamyabi
Nabiollah Kamyabi
Hannah JonesHannah Jones
Hannah Jones
ARAnubama Rajan
Anubama Rajan
UKUmesh Karandikar
Umesh Karandikar
KGK. Jane Grande-Allen
K. Jane Grande-Allen

4 July 2024 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
FMFernando H. Martins
Fernando H. Martins
TRThibaut Rosay
Thibaut Rosay
ARAnubama Rajan
Anubama Rajan
Hannah JonesHannah Jones
Hannah Jones
TTTayah Turocy
Tayah Turocy
VSVanessa Sperandio
Vanessa Sperandio